We are live on ! Find out more
CC

Colrain Capital Portfolio holdings

AUM $259M
1-Year Est. Return 63.6%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+63.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$55.6M
AUM Growth
-$41.5M
Cap. Flow
-$56.9M
Cap. Flow %
-102.44%
Top 10 Hldgs %
63.04%
Holding
32
New
1
Increased
2
Reduced
20
Closed
9

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.74M
2
VST icon
Vistra
VST
+$1.11M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$545K

Top Sells

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$8.34M
2
HES
Hess
HES
+$5.19M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.06M
4
CI icon
Cigna
CI
+$4.46M
5
AAPL icon
Apple
AAPL
+$4.31M

Sector Composition

Rank Sector Weight
1 Healthcare 21.87%
2 Technology 14.45%
3 Materials 11.42%
4 Communication Services 10.32%
5 Consumer Staples 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOW icon
26
Dow Inc
DOW
$21.6B
-2,875
Closed -$160K
GOOG icon
27
Alphabet (Google) Class C
GOOG
$3.9T
-600
Closed -$53K
MS icon
28
Morgan Stanley
MS
$337B
-400
Closed -$27K
OIH icon
29
VanEck Oil Services ETF
OIH
$2.06B
-1,000
Closed -$154K
PFE icon
30
Pfizer
PFE
$140B
-15,600
Closed -$574K
UAL icon
31
United Airlines
UAL
$38.4B
-3,260
Closed -$141K
C.PRS
32
DELISTED
Citigroup Inc. Depositary Shares, each representing a 1/1,000th interest in a share of 6.300% Noncum
C.PRS
-2,500
Closed -$64K

Similar funds

Colrain Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Colrain Capital held 32 positions worth $55.6M, down 43% from $97M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Colrain Capital withdrew a net $56.9M in Q2 2021, closing 9 positions and reducing 20 holdings. Its most notable exit was Pfizer, an estimated $574K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Materials.

Against the trend, Colrain Capital opened a new position in Vertex Pharmaceuticals worth $1.67M.

  • Colrain Capital's largest Q2 2021 buy was Vertex Pharmaceuticals: 8,300 shares worth $1.67M.
  • Colrain Capital added most to Vistra in Q2 2021, an estimated $1.11M increase.
  • Colrain Capital's biggest Q2 2021 reduction was The Mosaic Company, cutting an estimated $8.34M.
  • Colrain Capital fully exited Pfizer in Q2 2021, selling an estimated $574K.
  • Colrain Capital's ten largest holdings make up 63% of its $55.6M portfolio in Q2 2021.
  • Colrain Capital opened 1 new position and closed 9 in Q2 2021.
  • Colrain Capital's portfolio value fell 43% quarter-over-quarter to $55.6M.

Based on Colrain Capital's 13F filing for Q2 2021, filed 13 Aug 2021.